Green Chemistry Division of Minafin to serve as high-value conversion and manufacturing partner, improving downstream supply chain for novel chemistry.
Acquisition strengthens specialty medicines and respiratory pipeline with camlipixant, a highly selective P2X3 antagonist and potential best-in-class treatment for refractory chronic cough.
The center will host manufacturing-oriented seminars, such as improving wet/dry granulation processes and strategies for effective continuous manufacturing.